CRISPR-Cas9

Nucleic Acids and Gene Therapies in Neuromuscular Disorders

Aug 23, 2024

Nucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies

opportunities-and-challenges-for-cell-and-gene-therapies

Feb 05, 2024

Opportunities and Challenges for Cell and Gene Therapies

vertex-crispr-gene-editing-therapy-exa-cel

Apr 14, 2023

Vertex/CRISPR’s Gene-editing Therapy exa-cel: Inch Ahead of Rival

crispr-technology-market

Jun 10, 2022

Unraveling the Potential of CRISPR Technology in the Gene-editing Space

transthyretin amyloidosis

Jan 09, 2018

Notizia

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper